|
|
References
|
|
 
|
Al-Abed, Y., Dabideen, D., Aljabari, B., Valster, A., Messmer, D., Ochani, M., Tanovic, M., Ochani, K., Bacher, M., Nicoletti, F., Metz, C., Pavlov, V.A., Miller, E.J., Tracey, K.J. (2005) ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis. Journal of Biological Chemistry, 280(44): 36541
|
|
|
Bernhagen, J., Calandra, T., Bucala, R. (1998) Regulation of the immune response by macrophage migration inhibitory factor: Biological and structural features. J Mol Med, 76(3-4): 151-61
|
|
|
Cantor, J., Haskins, K. (2007) Recruitment and activation of macrophages by pathogenic CD4 T cells in type 1 diabetes: Evidence for involvement of CCR8 and CCL1. J. Immunol, 179, 5760-5767
|
|
|
Chambers, K.T., Unverferth, J.A., Weber, S.M., Wek, R.C., Urano, F., Corbett, J.A. (2007) The role of nitric oxide and the unfolded protein response in cytokine induced β-cell death. Diabetes, 57(1): 124
|
|
1
|
Cnop, M., Welsh, N., Jonas, J.-C., Jorns, A., Lenzen, S., Eizirik, D.L. (2005) Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes. Diabetes, 54 (Suppl. 2), S97-S107
|
|
|
Cvetković, I., Stošić-Grujičić, S. (2006) Neutralization of macrophage migration inhibitory factor: Novel approach for the treatment of immunoinflammatory disorders. International immunopharmacology, 6(10): 1527-1534
|
|
|
Cvetković, I., Al-Abed, Y., Miljković, Đ., Maksimović-Ivanić, D., Roth, J., Bacher, M., Lan, H.Y., Nicoletti, F., Stošić-Grujičić, S. (2005) Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes. Endocrinology, 146(7): 2942-2951
|
|
 22
|
Droge, W. (2002) Free radicals in the physiological control of cell function. Physiol Rev, 82(1): 47-95
|
|
|
Flodstrom-Tullberg, M., Yadav, D., Hagerkvist, R., Tsai, D., Secrest, P., Stotland, A., Sarvetnick, N. (2003) Target cell expression of suppressor of cytokine signaling-1 prevents diabetes in the NOD mouse. Diabetes, 52(11): 2696-700
|
|
|
Frigerio, S., Hollander, G.A., Zumsteg, U. (2002) Functional IL-18 Is produced by primary pancreatic mouse islets and NIT-1 beta cells and participates in the progression towards destructive insulitis. Horm Res, 57(3-4): 94-104
|
|
|
Hill, N.J., Hultcrantz, M., Sarvetnick, N., Flodstorm-Tullberg, M. (2007) The target tissue in autoimmunity: An influential niche. European Journal of Immunology, 37(3): 589
|
|
|
Issekutz, T.B. (1992) Inhibition of lymphocyte endothelial adhesion and in vivo lymphocyte migration to cutaneous inflammation by TA-3, a new monoclonal antibody to rat LFA-1. J Immunol, 149(10): 3394-402
|
|
|
Kaminitz, A., Stein, J., Yaniv, I., Askenasy, N. (2007) The vicious cycle of apoptotic beta-cell death in type 1 diabetes. Immunol. Cell Biol, DOI:10.1038/sj.icb.7100093
|
|
|
Lybetsky, J.B., Dios, A., Han, J., i dr. (2002) The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents. Journal of Biological Chemistry, 277(46): 44261
|
|
|
Mandrup-Poulsen, T. (2003) Beta cell death and protection. Ann N Y Acad Sci, 1005: 32-42
|
|
|
Miljković, Đ., Cvetković, I., Momčilović, M., Maksimović-Ivanić, D., Stošić-Grujičić, S., Trajković, V. (2005) Interleukin-17 stimulates inducible nitric oxide synthase-dependent toxicity in mouse beta cells. Cellular and molecular life sciences, 62(22): 2658-2668
|
|
|
Nicoletti, F., Creange, A., Orlikowski, D., Bolgert, F., Mangano, K., Metz, C., di Marco, R., al-Abed Y. (2005) Macrophage migration inhibitory factor (MIF) seems crucially involved in Gullain-Barre syndrome and experimental allergic neuritis. Journal of Neuroimmunology, 168(1-2): 168
|
|
|
Pavlovic, D., Chen, M.C., Bouwens, L., Eizirik, D.L., Pipeleers, D. (1999) Contribution of ductal cells to cytokine responses by human pancreatic islets. Diabetes, 48(1): 29-33
|
|
|
Pechhold, K., Patterson, N.B., Craighead, N., Lee, K.P., June, C.H., Harlan, D.M. (1997) Inflammatory cytokines IFN-gamma plus TNF-alpha induce regulated expression of CD80 (B7-1) but not CD86 (B7-2) on murine fibroblasts. J Immunol, 158(10): 4921-9
|
|
1
|
Rabinovitch, A., Suarez-Pinzon, W.L. (1998) Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol, 55(8): 1139-49
|
|
1
|
Steiner, L., Kroncke, K., Fehsel, K., Kolb-Bachofen, V. (1997) Endothelial cells as cytotoxic effector cells: Cytokine-activated rat islet endothelial cells lyse syngeneic islet cells via nitric oxide. Diabetologia, 40(2): 150-5
|
|
|
Stošić-Grujičić, S.D., Maksimović, D.D., Badovinac, V., Samardzić, T.S., Trajković, V.S., Lukić, M.L., Mostarica-Stojković, M.B. (2001) Antidiabetogenic effect of pentoxifylline is associated with systemic and target tissue modulation of cytokines and nitric oxide production. J Autoimmun, 16(1): 47-58
|
|
|
Stošić-Grujičić, S.D., Cvetković, I., Mangano, K., Fresta, M., Maksimović-Ivanić, D., Harhaji, L., Popadić, D., Momčilović, M., Miljković, Đ., Kim, J., Al-Abed, Y., Nicoletti, F. (2007) A potent immunomodulatory compound, (S, R)-3-phenyl-4, 5-dihydro-5-isoxasole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of stre. J. Pharmacol. Exp. Ther, 320, 1038-1049
|
|
|
Stošić-Grujičić, S.D., Stojanović, I.T., Maksimović-Ivanić, D.D., Momcilović, M., Popadić, D.M., Harhaji, L., Miljković, Đ.M., Metz, C., Mangano, K., Papaccio, G., al Abed, Y., Nicoletti, F. (2008) Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus. J. Cell. Physiol, 215(3): 665-675
|
|
|
Thomas, H.E., Darwiche, R., Corbett, J.A., Kay, T.W.H. (2002) Interleukin-1 plus gamma-interferon-induced pancreatic beta-cell dysfunction is mediated by beta-cell nitric oxide production. Diabetes, 51(2): 311-6
|
|
1
|
Weaver, C.T., Hatton, R.D., Mangan, P.R., Harrington, L.E. (2007) IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annual Review of Immunology, 25(1): 821
|
|
2
|
Yoon, J.W., Jun, H.S., Santamaria, P. (1998) Cellular and molecular mechanisms for the initiation and progression of beta cell destruction resulting from the collaboration between macrophages and T cells. Autoimmunity, 27(2): 109-22
|
|
|
|
|